IL6R and COVID-19: Having shown that IL-6 and sIL-6R serum levels are increased in acute severe COVID-19 patients, we sought to determine how much of the IL-6 is trapped in inactive complexes and how much is free and able to do harmful activities, thereby potentially contributing to COVID-19 pathology.